Article ; Online: Axi-cel in LBCL: fulfill two needs with one deed.
2022 Volume 140, Issue 21, Page(s) 2183–2185
MeSH term(s) | Humans ; Antigens, CD19 ; Immunotherapy, Adoptive ; Lymphoma, Large B-Cell, Diffuse ; Patient Reported Outcome Measures |
---|---|
Chemical Substances | axicabtagene ciloleucel (U2I8T43Y7R) ; Antigens, CD19 |
Language | English |
Publishing date | 2022-11-23 |
Publishing country | United States |
Document type | Editorial ; Comment |
ZDB-ID | 80069-7 |
ISSN | 1528-0020 ; 0006-4971 |
ISSN (online) | 1528-0020 |
ISSN | 0006-4971 |
DOI | 10.1182/blood.2022017564 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uh III Zs.140: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 364: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.